SCHEMBL10167658

SCHEMBL10167658

Cc1cccc2snc(NC(=O)c3ccc(Cl)nc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
RAB9A P51151 5/20 0.50
MEN1 O00255 3/20 0.50
NPC1 O15118 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
POLB P06746 1/20 0.50
CTNNB1 P35222 2/20 0.47
TCF7L2 Q9NQB0 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MDM4 O15151 1/20 0.45
TP53 P04637 1/20 0.45
MDM2 Q00987 1/20 0.45
KDR P35968 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
KCNQ3 O43525 2/20 0.44
KCNQ2 O43526 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167644 0.88 KMT2A (0.48) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL10167662 0.86 KMT2A (0.46) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL10167631 0.85 KCNQ3 (0.50) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL10167594 0.81 KCNQ3 (0.44) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL4064646 0.77 KMT2A (0.64) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL3782440 0.76 RAB9A (0.58) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL10167653 0.74 TRPV1 (0.42) KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL10167659 0.74 KCNQ3 (0.48) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL3787980 0.73 MDM4 (0.70) KMT2ARAB9AMEN1NPC1SMN1; SMN2
SCHEMBL3787990 0.69 KMT2A (1.00) KMT2ARAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 KMT2A 2749/4885RAB9A 1949/4885MEN1 3020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.